Markets › Pakistan › KAR › BFBIO

BF Biosciences Ltd

KAR:BFBIOHealth TechnologyPSX:ALLSHRPSX:KMIALLSHR

Rs 126.93+0.68%LiveIn session · ≈ AED 1.68 · Market cap $41.34M · Next earnings Wed 2 Dec

PKR billions	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.1	0.2	0.3	0.4	0.4	+0.9%
Cash & short-term investments	1.2	1.5	0.4	0.4	1.6	+258.9%
Receivables	0.2	0.2	0.1	0.3	0.2	−10.2%
Inventory	0.4	0.4	0.9	0.9	1.8	+101.6%
Total current assets	2.0	2.3	1.6	1.7	3.8	+128.8%
Property, plant & equipment	1.0	2.1	4.1	4.2	4.3	+3.1%
Total assets	3.0	4.4	5.7	5.8	8.4	+44.6%
Payables	0.2	0.1	0.2	0.3	0.3	+19.3%
Short-term debt	0.0	0.2	0.8	0.6	0.4	−42.5%
Total current liabilities	0.5	0.7	1.4	1.4	1.6	+13.7%
Long-term debt	0.9	1.5	1.8	1.6	1.4	−14.0%
Total debt	0.9	1.7	2.6	2.2	1.7	−22.0%
Net debt	(0.4)	0.2	2.2	1.8	0.2	−91.2%
Total liabilities	1.4	2.3	3.2	3.0	3.5	+13.6%
Total equity	1.5	1.8	2.0	2.4	4.7	+97.6%
Retained earnings	1.2	1.5	1.8	2.2	2.6	+20.6%

PKR billionsUpdated 30 Sep 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.